Literature DB >> 12183723

Idiopathic thrombocytopenic purpura diagnosed during the second decade of life.

Eric J Lowe1, George R Buchanan.   

Abstract

OBJECTIVE: To retrospectively review our institutional experience of adolescents with idiopathic thrombocytopenic purpura (ITP). STUDY
DESIGN: Medical record review of all patients diagnosed with ITP between the ages of 10 and 18 years seen at our center from January 1976 to March 2000.
RESULTS: Data were collected from 126 patients. Of the evaluable 110 cases, 63 (57%) satisfied the criteria for chronic ITP, 30 (27%) for acute ITP, and 17 (15%) were uncertain. Sex distribution and mean ages were similar in all 3 groups. Platelet count at presentation was higher in patients with chronic ITP. Splenectomy was performed in 24 patients, with 17 (77%) of 22 having normal platelet counts at last follow-up. Outcome for the nonsplenectomized patients with chronic ITP included normalization of platelet count (n = 4), minimal or no bleeding without treatment (n = 29), treatment for ongoing symptoms (n = 5), and unknown (n = 1). Two patients died, 1 from intracranial hemorrhage and 1 from Escherichia coli sepsis and pulmonary hemorrhage.
CONCLUSIONS: Patients 10 to 18 years of age with ITP are more likely than younger children to have chronic disease. Many patients with ITP recover without drug therapy or need for splenectomy. ITP in adolescents shares features of both childhood and adult ITP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183723     DOI: 10.1067/mpd.2002.125909

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

Review 1.  Clinical practice: immune thrombocytopenia in paediatrics.

Authors:  Veerle Labarque; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2014-01-05       Impact factor: 3.183

2.  Prevalence of primary immune thrombocytopenia in Oklahoma.

Authors:  Deirdra R Terrell; Laura A Beebe; Barbara R Neas; Sara K Vesely; Jodi B Segal; James N George
Journal:  Am J Hematol       Date:  2012-06-05       Impact factor: 10.047

3.  Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study.

Authors:  Masaru Kubota; Souichi Adachi; Ikuya Usami; Masayuki Okada; Toshiyuki Kitoh; Mitsutaka Shiota; Yoshihiro Taniguchi; Akihiko Tanizawa; Mitsuhiko Nanbu; Keigo Hamahata; Hisanori Fujino; Kousaku Matsubara; Yoshihiro Wakazono; Tatsutoshi Nakahata
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

4.  Prognostic Factors for Immune Thrombocytopenia Outcome in Greek Children: A Retrospective Single-Centered Analysis.

Authors:  Alexandros Makis; Athanasios Gkoutsias; Theodoros Palianopoulos; Eleni Pappa; Evangelia Papapetrou; Christina Tsaousi; Eleftheria Hatzimichael; Nikolaos Chaliasos
Journal:  Adv Hematol       Date:  2017-12-06

Review 5.  The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach.

Authors:  Rita Consolini; Giorgio Costagliola; Davide Spatafora
Journal:  Front Pediatr       Date:  2017-08-21       Impact factor: 3.418

6.  Biological stratification of clinical disease courses in childhood immune thrombocytopenia.

Authors:  David E Schmidt; Katja M J Heitink-Pollé; Bart Mertens; Leendert Porcelijn; Rick Kapur; C Ellen van der Schoot; Gestur Vidarsson; Johanna G van der Bom; Marrie C A Bruin; Masja de Haas
Journal:  J Thromb Haemost       Date:  2021-03-18       Impact factor: 5.824

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.